UK markets closed

Telesis Bio, Inc. (TBIO)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
4.5000+0.1500 (+3.45%)
At close: 04:00PM EDT
4.4010 -0.10 (-2.20%)
After hours: 07:35PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-45,242
-47,724
-48,471
-38,958
-18,010
Depreciation & amortisation
4,138
4,102
2,875
1,574
1,457
Stock-based compensation
3,573
3,963
3,727
1,086
43
Change in working capital
-2,192
-7,766
1,787
-3,037
-20
Accounts receivable
1,617
-1,332
-2,529
-735
-774
Inventory
-1,375
-1,825
168
-1,462
111
Other working capital
-28,749
-36,647
-43,183
-38,552
-15,585
Other non-cash items
722
765
482
333
706
Net cash provided by operating activities
-26,737
-34,667
-38,715
-36,698
-15,381
Cash flows from investing activities
Investments in property, plant and equipment
-2,012
-1,980
-4,468
-1,854
-204
Acquisitions, net
-
0
-556
-13,186
0
Purchases of investments
-26,618
-33,775
-77,428
0
-
Sales/maturities of investments
30,995
29,995
64,445
0
-
Net cash used for investing activities
2,381
-5,744
-18,007
-15,040
-204
Cash flows from financing activities
Debt repayment
-15,081
-15,092
-15,079
-5,081
-107
Common stock issued
-
-
0
112,484
0
Other financing activities
-
-
-752
-1,367
-
Net cash used provided by (used for) financing activities
11,556
11,565
4,510
121,081
-96
Net change in cash
-12,809
-28,849
-52,212
69,343
-15,681
Cash at beginning of period
23,532
30,594
82,806
13,463
29,144
Cash at end of period
10,723
1,745
30,594
82,806
13,463
Free cash flow
Operating cash flow
-26,737
-34,667
-38,715
-36,698
-15,381
Capital expenditure
-2,012
-1,980
-4,468
-1,854
-204
Free cash flow
-28,749
-36,647
-43,183
-38,552
-15,585